BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10360970)

  • 1. Regulation of NOD mouse autoimmune diabetes by T cells that recognize a TCR CDR3 peptide.
    Elias D; Tikochinski Y; Frankel G; Cohen IR
    Int Immunol; 1999 Jun; 11(6):957-66. PubMed ID: 10360970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOD mouse diabetes: the ubiquitous mouse hsp60 is a beta-cell target antigen of autoimmune T cells.
    Birk OS; Elias D; Weiss AS; Rosen A; van-der Zee R; Walker MD; Cohen IR
    J Autoimmun; 1996 Apr; 9(2):159-66. PubMed ID: 8738959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of NOD diabetes with a novel peptide of the hsp60 molecule induces Th2-type antibodies.
    Bockova J; Elias D; Cohen IR
    J Autoimmun; 1997 Aug; 10(4):323-9. PubMed ID: 9237795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta-cell antigens.
    Elias D; Meilin A; Ablamunits V; Birk OS; Carmi P; Könen-Waisman S; Cohen IR
    Diabetes; 1997 May; 46(5):758-64. PubMed ID: 9133541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hsp60 peptide p277 arrests the autoimmune diabetes induced by the toxin streptozotocin.
    Elias D; Cohen IR
    Diabetes; 1996 Sep; 45(9):1168-72. PubMed ID: 8772717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A shared TCR CDR3 sequence in NOD mouse autoimmune diabetes.
    Tikochinski Y; Elias D; Steeg C; Marcus H; Kantorowitz M; Reshef T; Ablamunits V; Cohen IR; Friedmann A
    Int Immunol; 1999 Jun; 11(6):951-6. PubMed ID: 10360969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice: modulation of spontaneous 60-kDa heat shock protein autoimmunity.
    Quintana FJ; Rotem A; Carmi P; Cohen IR
    J Immunol; 2000 Dec; 165(11):6148-55. PubMed ID: 11086048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of diabetes in standard mice by immunization with the p277 peptide of a 60-kDa heat shock protein.
    Elias D; Marcus H; Reshef T; Ablamunits V; Cohen IR
    Eur J Immunol; 1995 Oct; 25(10):2851-7. PubMed ID: 7589082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Th1-recognized peptide P277, when tandemly repeated, enhances a Th2 immune response toward effective vaccines against autoimmune diabetes in nonobese diabetic mice.
    Jin L; Zhu A; Wang Y; Chen Q; Xiong Q; Li J; Sun Y; Li T; Cao R; Wu J; Liu J
    J Immunol; 2008 Jan; 180(1):58-63. PubMed ID: 18097004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination of non-obese diabetic mice with a fragment of peptide P277 attenuates insulin-dependent diabetes mellitus.
    Ma YJ; Lu Y; Hou J; Dong YK; Du MZ; Xing Y; Ge CY; Xu ML; Jin L; Cao RY; Li TM; Wu J; Liu JJ
    Int Immunopharmacol; 2011 Sep; 11(9):1298-302. PubMed ID: 21530685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A self MHC class II beta-chain peptide prevents diabetes in nonobese diabetic mice.
    Chaturvedi P; Agrawal B; Zechel M; Lee-Chan E; Singh B
    J Immunol; 2000 Jun; 164(12):6610-20. PubMed ID: 10843721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Islet T cells secreting IFN-gamma in NOD mouse diabetes: arrest by p277 peptide treatment.
    Ablamunits V; Elias D; Reshef T; Cohen IR
    J Autoimmun; 1998 Feb; 11(1):73-81. PubMed ID: 9480725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intrathymic administration of mycobacterial heat shock protein 65 and peptide p277 on the development of diabetes in NOD mice: caution required in vaccination studies.
    Funda DP; Hartoft-Nielsen ML; Kaas A; Buschard K
    APMIS; 1998 Oct; 106(10):1009-16. PubMed ID: 9833705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of autoimmune diabetes and insulitis in NOD mice with heat shock protein 60 peptide p277.
    Elias D; Cohen IR
    Diabetes; 1995 Sep; 44(9):1132-8. PubMed ID: 7657040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide therapy for diabetes in NOD mice.
    Elias D; Cohen IR
    Lancet; 1994 Mar; 343(8899):704-6. PubMed ID: 7907681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential recognition of TCR hypervariable regions by human anti-idiotypic T cells induced by T cell vaccination.
    Zang YC; Hong J; Rivera VM; Killian J; Zhang JZ
    J Immunol; 2000 Apr; 164(8):4011-7. PubMed ID: 10754292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced immunogenicity of peptide P277 by heat shock protein HSP65 vector carrying tandem repeats of P277 to prevent type 1 diabetes in NOD mice.
    Liang J; Aihua Z; Yu W; Jingjing L
    Exp Clin Endocrinol Diabetes; 2008 Oct; 116(9):541-8. PubMed ID: 18473288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
    Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
    J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide p277 of HSP60 signals T cells: inhibition of inflammatory chemotaxis.
    Nussbaum G; Zanin-Zhorov A; Quintana F; Lider O; Cohen IR
    Int Immunol; 2006 Oct; 18(10):1413-9. PubMed ID: 16893923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mutant P277 peptide VP to ameliorate atherogenic side-effects and to preserve anti-diabetic effects in NOD mice.
    Zhang Y; Lu S; Alahdal M; Gao H; Shen Y; Pan Y; Wu J; Xing Y; Jin L
    Exp Cell Res; 2018 Oct; 371(2):399-408. PubMed ID: 30179603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.